D.E. Shaw & Co’s Medifast MED Stock Holding History

D.E. Shaw & Co’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,000	Closed	-$607K	–	4565
2025 Q1	$607K	Sell	45,000 -30,700	-41%	-$461K	﹤0.01%	3385
2024 Q4	$1.33M	Sell	75,700 -14,300	-16%	-$265K	﹤0.01%	3029
2024 Q3	$1.72M	Sell	90,000 -100,000	-53%	-$1.93M	﹤0.01%	2821
2024 Q2	$4.15M	Buy	190,000 +90,000	+90%	+$2.4M	﹤0.01%	2005
2024 Q1	$3.83M	Buy	+100,000	New	+$4.84M	﹤0.01%	2092
2023 Q2	–	Sell	-45,900	Closed	-$4.76M	–	4418
2023 Q1	$4.76M	Buy	45,900 +35,900	+359%	+$3.98M	0.01%	1969
2022 Q4	$1.15M	Buy	10,000 +3,000	+43%	+$349K	﹤0.01%	3337
2022 Q3	$759K	Sell	7,000 -10,000	-59%	-$1.43M	﹤0.01%	3781
2022 Q2	$3.07M	Buy	17,000 +7,000	+70%	+$1.25M	﹤0.01%	2688
2022 Q1	$1.71M	Sell	10,000 -21,300	-68%	-$4.02M	﹤0.01%	3458
2021 Q4	$6.55M	Buy	+31,300	New	+$6.47M	0.01%	2092
2021 Q3	–	Sell	-10,000	Closed	-$2.83M	–	5112
2021 Q2	$2.83M	Hold	10,000	–	–	﹤0.01%	2581
2021 Q1	$2.12M	Buy	+10,000	New	+$2.39M	﹤0.01%	2538
2020 Q3	–	Sell	-20,300	Closed	-$2.82M	–	4017
2020 Q2	$2.82M	Hold	20,300	–	–	﹤0.01%	2125
2020 Q1	$1.27M	Buy	+20,300	New	+$1.85M	﹤0.01%	2550
2019 Q1	–	Sell	-15,000	Closed	-$1.88M	–	3787
2018 Q4	$1.88M	Hold	15,000	–	–	﹤0.01%	2212
2018 Q3	$3.32M	Hold	15,000	–	–	﹤0.01%	1840
2018 Q2	$2.4M	Buy	+15,000	New	+$1.92M	﹤0.01%	2096
2018 Q1	–	Sell	-3,200	Closed	-$223K	–	3659
2017 Q4	$223K	Buy	+3,200	New	+$212K	﹤0.01%	3384

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co's MED Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Medifast (MED) stake by 42% in Q2 2026, selling an estimated $787K and leaving 92,345 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #3762.

D.E. Shaw & Co first reported a position in MED in Q1 2014 and has held it in 37 quarters since. The position peaked at $8.93M in Q1 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

D.E. Shaw & Co held 92,345 shares of Medifast worth $980K as of Q2 2026.
D.E. Shaw & Co sold 68,219 Medifast shares in Q2 2026, an estimated $787K.
Medifast made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3762 holding.
D.E. Shaw & Co first reported a position in Medifast in Q1 2014 and has held it in 37 quarters since.
D.E. Shaw & Co's Medifast position peaked at $8.93M in Q1 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.